Literature DB >> 8086540

Successful treatment of antimony-resistant cutaneous leishmaniasis with liposomal amphotericin B.

J Torre-Cisneros, J L Prada, J L Villanueva, F Valverde, P Sánchez-Guijó.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8086540     DOI： 10.1093/clinids/18.6.1024

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  3 in total

1.  Lipsosomal amphotericin B for treatment of cutaneous leishmaniasis.

Authors:  Glenn Wortmann; Michael Zapor; Roseanne Ressner; Susan Fraser; Josh Hartzell; Joseph Pierson; Amy Weintrob; Alan Magill
Journal:  Am J Trop Med Hyg       Date:  2010-11       Impact factor: 2.345

Review 2.  Therapeutic options for old world cutaneous leishmaniasis and new world cutaneous and mucocutaneous leishmaniasis.

Authors:  Begoña Monge-Maillo; Rogelio López-Vélez
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

3.  Activity of liposomal amphotericin B against experimental cutaneous leishmaniasis.

Authors:  V Yardley; S L Croft
Journal:  Antimicrob Agents Chemother       Date:  1997-04       Impact factor: 5.191
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.